Compumedics Limited · ASX:CMP
Compumedics — Shareholder Meeting (October 2003)
20 slides from Compumedics's shareholder meeting presentation, Oct 23, 2003
Slide 1: Slide 1
Slide 2: Slide 2
Slide 3: Slide 3
Slide 4: Slide 4
Slide 5: Revenue growth
Revenue growth _ 62% year on year $3.0m turnaround at the EBITDA line _ to $2.1m profit Adjustments for certain assets | taken now Operating cash positive H2 Sleep USA grows 50% year on year. Sieep Europe grows 45% year on year. Excluding Neuroscan acquisition revenue growth 30 Growth of business le
Slide 6: Accounting adjustments, June 2003
— Y 12 mt s to | oe Accounting | June 30 2003 | June 30 dune 30 : : 2002 2003 adjustments pre-accounting | adjustments Operating ae eee | Revenue
Slide 7: June 2003 results compared to prior corresponding period
a ebae sulla ae to PCP June 2003 A#039;000
Slide 8: Slide 8
Slide 9: Slide 9
Slide 10: Revenue by region
Revenue by region Sr
Slide 11: Slide 11
Slide 12: Slide 12
Slide 13: Slide 13
Slide 14: Slide 14
Slide 15: Slide 15
Slide 16: Slide 16
Slide 17: Slide 17
Slide 18: Slide 18
Slide 19: Slide 19
Slide 20: Slide 20
Compumedics — Shareholder Meeting (October 2003) on 6ix